Molecular similarity considerations in the licensing of orphan drugs

Franco, P., Porta, N., Holliday, J.D. et al. (1 more author) (2017) Molecular similarity considerations in the licensing of orphan drugs. Drug Discovery Today, 22 (2). pp. 377-381. ISSN 1359-6446

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2016 Elsevier. This is an author produced version of a paper subsequently published in Drug Discovery Today. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Keywords: Molecular similarity; orphan drug legislation; rare diseases
Dates:
  • Accepted: 30 November 2016
  • Published (online): 10 December 2016
  • Published: February 2017
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Social Sciences (Sheffield) > Information School (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 06 Dec 2016 16:41
Last Modified: 29 Jan 2018 11:48
Published Version: https://doi.org/10.1016/j.drudis.2016.11.024
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.drudis.2016.11.024

Share / Export

Statistics